118 related articles for article (PubMed ID: 3778510)
1. Subcellular and extracellular localization of specific binding sites for triphenylethylene antiestrogens in human breast cancer.
Gulino A; Vacca A; Modesti A; Screpanti I; Farina A; Frati L
Biochem Pharmacol; 1986 Nov; 35(21):3863-70. PubMed ID: 3778510
[TBL] [Abstract][Full Text] [Related]
2. Studies on the ligand specificity and potential identity of microsomal antiestrogen-binding sites.
Watts CK; Sutherland RL
Mol Pharmacol; 1987 May; 31(5):541-51. PubMed ID: 3553893
[TBL] [Abstract][Full Text] [Related]
3. Resistance to tamoxifen with persisting sensitivity to estrogen: possible mediation by excessive antiestrogen binding site activity.
Pavlik EJ; Nelson K; Srinivasan S; Powell DE; Kenady DE; DePriest PD; Gallion HH; van Nagell JR
Cancer Res; 1992 Aug; 52(15):4106-12. PubMed ID: 1638522
[TBL] [Abstract][Full Text] [Related]
4. Microsomal binding sites for antioestrogens in rat liver. Properties and detergent solubilization.
Watts CK; Sutherland RL
Biochem J; 1986 Jun; 236(3):903-11. PubMed ID: 3790095
[TBL] [Abstract][Full Text] [Related]
5. Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites.
Katzenellenbogen BS; Miller MA; Mullick A; Sheen YY
Breast Cancer Res Treat; 1985; 5(3):231-43. PubMed ID: 4027393
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogen binding site and estrogen receptor mediate uptake and distribution of 4-hydroxytamoxifen-targeted doxorubicin-formaldehyde conjugate in breast cancer cells.
Burke PJ; Kalet BT; Koch TH
J Med Chem; 2004 Dec; 47(26):6509-18. PubMed ID: 15588086
[TBL] [Abstract][Full Text] [Related]
7. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
Miller MA; Lippman ME; Katzenellenbogen BS
Cancer Res; 1984 Nov; 44(11):5038-45. PubMed ID: 6488162
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of the role of antiestrogen-binding sites in mediating the growth modulatory effects of antiestrogens: studies using t-butylphenoxyethyl diethylamine, a compound lacking affinity for the estrogen receptor.
Sheen YY; Simpson DM; Katzenellenbogen BS
Endocrinology; 1985 Aug; 117(2):561-4. PubMed ID: 4017947
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of the microsomal tamoxifen binding site.
Kedjouar B; de Médina P; Oulad-Abdelghani M; Payré B; Silvente-Poirot S; Favre G; Faye JC; Poirot M
J Biol Chem; 2004 Aug; 279(32):34048-61. PubMed ID: 15175332
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogen binding sites in microsomal fractions of malignant and nonmalignant human breast tissues.
Mehta RR; DasGupta TK
Breast Cancer Res Treat; 1987; 9(1):61-7. PubMed ID: 3593991
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic stimulation of the antiestrogen specific binding site in rat uterus and liver.
Winneker RC; Clark JH
Endocrinology; 1983 Jun; 112(6):1910-5. PubMed ID: 6682755
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen inhibition of prolactin action in the mouse mammary gland.
Biswas R; Vonderhaar BK
Endocrinology; 1991 Jan; 128(1):532-8. PubMed ID: 1846110
[TBL] [Abstract][Full Text] [Related]
13. Antiestrogen binding sites in brain and pituitary of ovariectomized rats.
Gray JM; Ziemian L
Brain Res; 1992 Apr; 578(1-2):55-60. PubMed ID: 1511289
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanisms for the agonist actions of tamoxifen and the antagonist actions of MER-25 (ethamoxytriphetol) in the mouse uterus.
Lyman SD; Jordan VC
Biochem Pharmacol; 1985 Aug; 34(15):2795-806. PubMed ID: 4015716
[TBL] [Abstract][Full Text] [Related]
15. Interactions of tamoxifen in the chicken.
Lazier CB
J Steroid Biochem; 1987; 27(4-6):877-82. PubMed ID: 3320566
[TBL] [Abstract][Full Text] [Related]
16. Estrogen and antiestrogen binding sites in desmoid tumors.
Lim CL; Walker MJ; Mehta RR; Das Gupta TK
Eur J Cancer Clin Oncol; 1986 May; 22(5):583-7. PubMed ID: 3770030
[TBL] [Abstract][Full Text] [Related]
17. Characterization of an antiestrogen-binding protein in high salt extracts of human breast cancer tissue.
Kon OL
J Steroid Biochem; 1985 Feb; 22(2):177-86. PubMed ID: 3982029
[TBL] [Abstract][Full Text] [Related]
18. Characterization of estrogen and antiestrogen binding to the cytosol and microsomes of breast tumors.
Lopes MC; Tavares MC; Vale MG; Carvalho AP
J Steroid Biochem Mol Biol; 1991 Sep; 39(3):343-52. PubMed ID: 1911424
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogen binding within different pituitary cell populations. Comparison with androgen and estrogen receptors.
Thieulant ML; Adelaide J; Duval J
J Steroid Biochem; 1986 Jan; 24(1):395-9. PubMed ID: 3702423
[TBL] [Abstract][Full Text] [Related]
20. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism.
Payré B; de Medina P; Boubekeur N; Mhamdi L; Bertrand-Michel J; Tercé F; Fourquaux I; Goudounèche D; Record M; Poirot M; Silvente-Poirot S
Mol Cancer Ther; 2008 Dec; 7(12):3707-18. PubMed ID: 19074846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]